Tilray Brands, Inc. (TLRY)
Grows and sells cannabis, beverages, and wellness products across North America and Europe.
$4.02-0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-29.5%
The outlook
Tilray trades near its 52-week low, well below both its 50- and 200-day averages, suggesting a weak near-term trend. Analysts lean bullish with a buy consensus and an average price target implying roughly 125% upside from current levels. The overall market score leans bearish, reflecting the disconnect between analyst sentiment and recent price momentum.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 8 analysts
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +125% vs current price
Analyst price target
~12-month · 8 analysts$9.05average target+125.1% vs now
Now $4.02
Low $5.00High $23.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$496.3M
52-wk high
$23.20
52-wk low
$3.80
50-day avg
$4.79
200-day avg
$8.04
Trailing P/E
—